ST0313ENG - A real breakthrough in Implantology Roxolid SLActive

A Real Breakthrough in Implantology.

Roxolid® SLActive® – Setting New Standards, Reducing Invasiveness

1

L2_ROXOLID SLActive_FLYER.indd 1

18.09.13 13:48

Excellent performance scientifically proven.

Roxolid® is a unique dental implant material specifically designed for the use in dental implantology. The innovative metal alloy consists of titanium and zirconium. Roxolid® SLActive® Implants feature our hydrophilic SLActive® surface. Thus, they combine high mechanical strength with excellent osseointegration properties, which has been shown in numerous studies.

The growing scientific evidence reinforces that Roxolid® SLActive® is Straumann’s best material-surface combination.

Tensile strength (MPa)

1000

Mechanical tests have demonstrated a higher tensile strength of Roxolid®2 compared to annealed1 and cold-worked2 titanium.

800

600

400 ASTM TiGr4¹

Straumann cold-worked TiGr4²

Straumann® Roxolid®²

Preclinical studies in dogs showed that SLActive® Implants promote the production of significantly greater and more mature bone than SLA®. This outcome suggests that SLActive® may have a high potential to support osseointegration in dehiscence-type defects3,4.

SLActive®

SLA®

Histological evaluation of the defect around SLActive® and SLA® Implants after 12 weeks. On SLActive® there is a complete filling of the defect with new bone (80 % BIC), while on SLA® the new bone formation is only in the most apical part of the defect (5 % BIC).

2

L2_ROXOLID SLActive_FLYER.indd 2

18.09.13 13:48

Roxolid® is one of the most significant advances in the last 20 years

Dr. Paul A. Fugazzotto (USA)

70

SLActive® SLA®

% of new bone on the imlpant surface

60 50 40 30 20 10 0 0

1

2

3

4

5

6

Healing periods in weeks

% mean value (SD)

7 days

14 days

28 Days

42 days

SLActive®

6.14 (10.63)

14.80 (15.37)

48.34 (14.91)

61.62 (4.98)

SLA®

6.47 (6.02)

12.19 (10.62)

32.38 (16.21)

61.53 (5.79)

The excellent osseointegration process with SLActive® has been demonstrated histologically for the first time in humans5.

Table 1: Percentage of BIC after 7, 14, 28 and 42 days

A clinical multi-center study has demonstrated high survival (98.8 %) and success rates of small-diameter implants after 3 years6.

1 Norm ASTM F67 (states min. tensile strength of annealed titanium). 2 Data on file for Straumann cold-worked titanium and Roxolid® Implants.

3 Schwarz, F., et al., Bone regeneration in dehiscence-type defects at chemically modified (SLActive®) and conventional SLA titanium implants: a pilot study in dogs. J Clin.Periodontol. 34.1 (2007): 78–86 4 Schwarz, F., et al., Bone regeneration in dehiscence-type defects at non-submerged and submerged chemically modified (SLActive®) and conventional SLA titanium implants: an immunohistochemical study in dogs. J Clin.Periodontol. 35.1 (2008): 64–75.

5 Lang NP, et al., Early osseointegration to hydrophilic and hydrophobic implant surfaces in humans. Clin. Oral Implants Res. 2011;22:349–356. 6 Storelli, Three-year follow-up of a randomized, controlled, double-blind, clinical trial comparing two different implant alloys (Titanium Grade IV vs. Titanium Zircon) in the edentulous mandibles in a split-mouth design. Europerio 2012, Vienna.

3

L2_ROXOLID SLActive_FLYER.indd 3

18.09.13 13:48

Demographic Trend Requires New Solutions.

The demographic trend clearly presents a considerable challenge to dental professionals: As people’s life expectancy is increasing, there is a huge need for long-lasting products of highest quality. In addition, the share of the elderly in the population is increasing. As a consequence, when it comes to dental implant treatment, dental professionals are confronted with: pp

a rising number of compromised patients

pp

higher risk factors and

pp

more cases with limited bone availability and quality

The demand for products that can help reduce the treatment complexity and the need for invasive grafting procedures is high.

What are the benefits of a less invasive treatment?

In cases where invasive grafting procedures can be avoided, the benefits are numerous:

Your benefits*

Your patients’ benefits*

Decreased treatment time for you and your patients Reduced post-surgical complications

pp

Less complexity

pp

Less operative trauma

pp

Potential to gain more

pp

Less expensive

patients for implant

pp

Faster healing and less pain

treatment pp

Less post-operative discomfort

* Compared to a procedure with GBR

4

L2_ROXOLID SLActive_FLYER.indd 4

18.09.13 13:48

A Real Breakthrough in Implantology.

Roxolid® SLActive® – Setting New Standards, Reducing invasiveness

Greater confidence with Roxolid® SLActive® Roxolid® SLActive® is Straumann’s best material-surface combination linking outstanding mechanical strength with excellent osseointegration properties.

Eliminate invasive grafting procedures Roxolid® SLActive® Implants allow you to choose smaller sized implants if a GBR procedure can be avoided. As a consequence, dental implant treatment has the potential to become less invasive and less complex.

Increase patient acceptance Treating patients without invasive grafting procedures, gives you the opportunity to offer your patients a less traumatic, faster treatment at a lower cost. Such dental implant treatment will be more appealing to your patients; as a result more patients might seek treatment.

A Broadened Portfolio – New Possibilities To ensure a wider accessibility of Roxolid® SLActive® Implants, they are now available: p

in all diameters

p

in all lengths

p

as 4 mm Short Implant Line

p

with the new Loxim™ Transfer Piece

S

SP

NNC

S Straumann® Standard Implant SP Straumann® Standard Plus Implant NNC Straumann® Narrow Neck CrossFit ® Implant

4SI

4SI TE BL

TE

BL

Straumann® 4 mm Short Implant Straumann® Tapered Effect Implant Straumann® Bone Level Implant

5

L2_ROXOLID SLActive_FLYER.indd 5

18.09.13 13:48

Loxim™ Transfer Piece – The Easy Way Of Handling Implants.

The Straumann® Roxolid® SLActive® Implants will be delivered with the new Loxim™ Transfer Piece, which is connected to the implant with a snap-in mounting. Its new design offers various new features and benefits: Features

Benefits

pp

Snap-in mounting…

pp

…for easy handling without counter-maneuvering

pp

Blue color…

pp

…for high visibility

pp

Compact dimensions…

pp

…for easy access

pp

Height markings…

pp

…for correct implant placement

pp

Pre-determined breaking point…

pp

…for protecting the inner implant configuration

Compared to the screw-retained transfer piece, the Loxim™ offers you many advantages: Easier handling with the Loxim™ Transfer Piece Old

Screw-retained transfer piece

New pp

No holding key

pp

No counter-maneuvering

pp

Detaches with adapter

Loxim™ Transfer Piece

6

L2_ROXOLID SLActive_FLYER.indd 6

18.09.13 13:48

Vertical space is no longer a limitation.

The new Straumann® 4mm Short Implant …

… is Straumann‘s shortest Roxolid® SLActive® Implant and the shortest Tissue Level implant on the market.

It is perfectly suitable for partially and fully edentulous patients with limited vertical bone availability in the posterior region.

Thus, the 4mm Short Implant offers you additional treatment options and the possibility to treat patients without complex vertical bone augmentations.

Features

Benefits

pp

Internal synOcta® connection …

… ensures compatibility with the existing Tissue Level prosthetic portfolio

pp

Well-known Standard Plus Implant design …

… for easy oral hygiene in the posterior region

pp

Bone Level thread design …

… helps to increase primary stability

pp

Standard Straumann surgical procedure …

… requires no additional instruments

5-year success story with 4 mm Short Implants 5-year data of a multi-center study with the 4mm Short Implant with fixed partial dentures in severely resorbed posterior mandibles1 indicate: pp

a high survival rate of 94 % with 4 mm Short Implants1 and

pp

a mean marginal bone loss of 0.5 mm after 5 years

Conclusion: Fixed partial dentures can be supported by 4 mm Short Implants in severely atrophic mandibles without the need of a bone augmentation1.

1 Slotte Christer et al, Four-mm implants supporting fixed partial dentures in the posterior mandible. 5-year results from a multicenter study.

Presented at the 20th Annual Scientific Meeting of the European Association of Osseointegration, 10-13 October 2012, Copenhagen, Denmark.

7

L2_ROXOLID SLActive_FLYER.indd 7

18.09.13 13:48

The New Standard For Less Invasive Treatment Procedures.

Conventional

Less invasive

Roxolid® SLActive® Implants allow you to choose smaller diameter implants in order to avoid invasive grafting procedures.

Roxolid® SLActive® 4 mm Short Implants allow you to treat your patients with severely atrophied posterior mandibles without complex vertical bone augmentations.

Roxolid® SLActive® 4 mm Short Implants may reduce the invasiveness and the complexity of implant cases.

Straumann products are CE marked 09/13

International Headquarters Institut Straumann AG Peter Merian-Weg 12 CH-4002 Basel, Switzerland Phone +41 (0)61 965 11 11 Fax +41 (0)61 965 11 01

© Institut Straumann AG, 2013. All rights reserved.

Straumann® and/or other trademarks and logos from Straumann® mentioned herein are the trademarks or registered trademarks of Straumann Holding AG and/or its affiliates. All rights reserved.

www.straumann.com

L2_ROXOLID SLActive_FLYER.indd 8

18.09.13 13:48